Registration Dossier

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

The substance showed delayed contact hypersensitivity in all 20/20 animals.

The substance has been manufactured since 1985 in Japan, and company has no adversed data based on company's health diagnose including workers' difficulty on respirable system.

The substance has a potential to skin sensitising but there is no available data on human.


Migrated from Short description of key information:
The substance is a potential to skin sensitiser but there is no available data on human to support this.

Respiratory sensitisation

Endpoint conclusion
Additional information:

Data waving; Particle size of this product is more than 355 um and this product is practically not including any respirable fraction.


Migrated from Short description of key information:
no data in animals

Justification for classification or non-classification

The substance is classified as skin sensitising category 1 in accordance with GHS.